Top 20 Pharma Exceeds Recruitment Targets and Reduces Screen Failures Across 188 Sites

A top-20 pharmaceutical company was conducting a Phase III breast cancer study in 16 countries across North America, Europe, and Asia.

The sponsor’s CRO leveraged Advarra Study Collaboration solution to provide dedicated study startup and enrollment technology designed to facilitate optimal execution of this complex study, and to provide information and support tools to sites in order to increase engagement.

Read more on how Advarra Study Startup and Advarra Enroll has proven to be a technology that can help make clinical trails more manageable.